PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Respiratory Section, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.\', \'Azienda Ospedaliera Universitaria Ferrara, Ferrara, Italy.\', \'Department of Physics and Earth Sciences University of Ferrara, Ferrara, Italy.\', \'National Institute of Nuclear Physics, INFN Sezione di Ferrara, Ferrara, Italy.\', \'Laboratory for Technologies of Advanced Therapies, University of Ferrara, Ferrara, Italy.\', \'Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.\', \'Cardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy.\', \'Intensive Care Unit, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.\', \'Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia.\', \'National Heart and Lung Institute, Imperial College London, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.648004
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33767713
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients.
?:type

Metadata

Anon_0  
expand all